Medifast MED Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Medifast in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medifast's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medifast's additional paid-in capital?
- Medifast (MED) reported additional paid-in capital of $41.49M in Q1 2026.
- How has Medifast's additional paid-in capital changed year-over-year?
- Medifast's additional paid-in capital increased by 19.6% year-over-year, from $34.7M to $41.49M.
- What is the long-term trend for Medifast's additional paid-in capital?
- Over 5 years (2020 to 2025), Medifast's additional paid-in capital has grown at a 38.8% compound annual growth rate (CAGR), from $7.84M to $40.41M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.